Sponsor Pipeline

Kevin Kim, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07237100 Mirdametinib in Patients With Advanced NF1-mutant Melanoma Advanced Unresectable Melanoma Recruiting
Disease Areas
Melanoma (1)
Get alerts when Kevin Kim, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free